We are monitoring the impact of COVID-19 on North America Cell Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date July, 2021
ID: 11875
Share on
Share on

North America Cell Therapy Market Research Report – Segmented By Technology, Type, Cell Source, Application, End-Users and Country (The United States, Canada and Rest of North America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: July, 2021
ID: 11875
Pages: 100

North America Cell Therapy Market Size (2021 to 2026)

The size of the North American cell therapy market is estimated to be growing at a promising rate of 7.5% CAGR from 2021 to 2026.

The market's growth is expected to be driven by the increasing attention to the development of regenerative therapies with an increasing emphasis on innovations and manufacturing. In addition, the availability of a significant number of products approved for clinical use is expected to continue the growth of the market during the forecast period. Other factors driving the growth rate include an increase in approval of clinical trials in cell biology research, growing demand for regenerative treatment regimes, and an advance in R&D development to initiate therapeutic options for chronic diseases.

The cell therapy market is growing, along with the increase in clinical trials in the region. North America, especially the United States, has conquered the overall market regarding the number of cell therapy trials. Stem cells play an important role in regenerative medicine, especially in the field of dermatology. However, oncology is expected to register the highest growth rate due to many products being developed for the treatment of cancer. Furthermore, with the increase in regenerative medicine centers, the cell therapy market is also expected to grow in the future.

In addition, stem cell banks are gaining interest with the support of government initiatives. As a result, the stem cell banks are increasing in the region, aiding in the market's growth. Besides, the growing awareness of stem cell storage among people has also positively affected the market.

However, several countries and region-specific conditions are implemented to allow further processing and testing; many existing trials and readings have been delayed. New trials have been halted altogether, so strict regulations are likely to restrict the market growth.

Impact of COVID-19 on the North American Cell Therapy Market:

The COVID-19 pandemic offers lucrative opportunities for companies operating in the cell therapy market to accelerate cell therapy research that could work against COVID-19. North America is negatively affected by the pandemic.

On the other hand, the pandemic provides research and development opportunities for various biotechnology and biopharmaceutical companies to introduce treatment options through vaccines and drugs and cell therapies such as plasma therapy to save lives around the world. However, advances in biotechnology have allowed companies to innovate in treatment through the use of cell therapy.

For example, in 2020, Celltex Therapeutics Corporation stated that it had received approval from the United States FDA to continue with Celltex's Investigational new drug use. The submitted application is to study the prophylactic efficiency of autologous adipose tissue extirpated from stem mesenchyme cells to treat COVID-19. The research results have shown promise in tackling the symptoms and complications associated with COVID-19. These advances in cell therapy to treat COVID-19 are likely to drive the growth of the North American cell therapy market in the coming years.

This research report on the North American cell therapy market has been segmented and sub-segmented into the following categories:

By Technology:

  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology

By Type:

  • Autologous
  • Allogeneic

By Cell Source:

  • iPSCs
  • Bone Marrow
  • Umbilical Cord Blood-Derived Cells
  • Adipose Tissues
  • Neural Stem Cell

By Application:

  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Wounds & Injuries
  • Ocular
  • Others

By End-User:

  • Hospitals & Clinics
  • Regenerative Medicine Centres
  • Diagnostic & Research Centres
  • Others

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American cell therapy market is expected to achieve the most significant share in the global market during the forecast period due to factors such as increased collaborative efforts to promote cell therapy and developments in cell therapy against COVID-19. According to estimates from the National Cancer Institute, 1,735,400 new cancer cases are expected to be diagnosed in the United States, and 609,690 are expected to die from the disease. The increasing diseases prevalence can be attributed to population growth.

The increasing prevalence of the population suffering from cardiovascular diseases, cancer, and other diseases is expected to affect the market's growth positively. In addition, the increased initiatives by authorities and governments to improve healthcare systems and publicize the benefits of cell therapy are also expected to increase the growth of the North American cell therapy market.

KEY MARKET PARTICIPANTS:

Merck KGaA and Thermo Fisher Scientific Inc, Lonza Group, Osiris Therapeutics, Inc., Danaher Corporation, Becton, Dickinson and Company, Sartorius AG, Fresenius Medical Care AG & Co. KGaA, FUJIFILM Irvine Scientific, Corning Incorporated, Mesoblast Ltd., Medipost Co., Ltd. Avantor, Inc., CellGenix GmbH, Bio-Techne Corporation, STEMCELL Technologies, SIRION Biotech GmbH, and Hemasoft are a few of the noteworthy companies operating in the North American cell therapy market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. By Technology
      1. Somatic Cell Technology
      2. Cell Immortalization Technology
      3. Viral Vector Technology
      4. Genome Editing Technology
      5. Cell Plasticity Technology
      6. Three-Dimensional Technology
      7. Y-o-Y Growth Analysis, By Technology
      8. Market Attractiveness Analysis, By Technology
      9. Market Share Analysis, By Technology
    2. By Type
      1. Autologous
      2. Allogeneic
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    3. By Cell Source
      1. iPSCs
      2. Bone Marrow
      3. Umbilical Cord Blood-Derived Cells
      4. Adipose Tissues
      5. Neural Stem Cell
      6. Y-o-Y Growth Analysis, By Cell Source
      7. Market Attractiveness Analysis, By Cell Source
      8. Market Share Analysis, By Cell Source
    4. By Application
      1. Musculoskeletal
      2. Cardiovascular
      3. Gastrointestinal
      4. Neurological
      5. Oncology
      6. Dermatology
      7. Wounds & Injuries
      8. Ocular
      9. Others
      10. Y-o-Y Growth Analysis, By Application
      11. Market Attractiveness Analysis, By Application
      12. Market Share Analysis, By Application
    5. By End-User
      1. Hospitals & Clinics
      2. Regenerative Medicine Centres
      3. Diagnostic & Research Centres
      4. Others
      5. Y-o-Y Growth Analysis, By End-User
      6. Market Attractiveness Analysis, By End-User
      7. Market Share Analysis, By End-User
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. North America
      1. The United States
      2. Canada
      3. Rest of North America
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Merck KGaA
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Thermo Fisher Scientific Inc.
    3. Lonza Group
    4. Osiris Therapeutics, Inc.
    5. Danaher Corporation
    6. Becton, Dickinson, and Company
    7. Sartorius AG
    8. Fresenius Medical Care AG & Co. KGaA
    9. FUJIFILM Irvine Scientific
    10. Corning Incorporated
    11. Mesoblast Ltd.
    12. Medipost Co., Ltd.
    13. Avantor, Inc.
    14. CellGenix GmbH
    15. Bio-Techne Corporation
    16. STEMCELL Technologies
    17. SIRION Biotech GmbH
    18. Hemasoft
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, type, cell source, application, end-users along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

Cell Therapy Market

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample